Inventiva (IVEVF) Profit After Tax (2019 - 2023)
Inventiva (IVEVF) posted Profit After Tax of -$945751.2 for Q4 2023, up 96.85% on a QoQ basis from -$30.1 million in Q4 2022, and up 96.85% year-over-year from -$480432.6 in Q4 2022.
Analysis
Inventiva (IVEVF) Profit After Tax (2019 - 2023) Analysis & Trends
Inventiva has reported Profit After Tax for 5 years, with the latest figure at -$945751.2 in Q4 2023.
- On a quarterly basis, Profit After Tax rose 96.85% year-over-year to -$945751.2 in Q4 2023; TTM through Dec 2023 was -$58.9 million, a 39.93% increase from a year earlier, with the FY2025 full-year figure at $412.2 million, up 109.42% from the prior year.
- Profit After Tax was -$945751.2 for Q4 2023 at Inventiva, up from -$30.1 million in the prior quarter.
- The five-year high for Profit After Tax was -$945751.2 in Q4 2023, with the low at -$40.1 million in Q4 2020.
- Average Profit After Tax over 5 years is -$18.7 million, with a median of -$13.9 million recorded in 2021.
- The sharpest annual moves came in 2021 and 2023: Profit After Tax sank 76.4% in 2021, then jumped 96.85% in 2023.
- Over 5 years, Profit After Tax stood at -$33.4 million in 2019, then slipped by 19.84% to -$40.1 million in 2020, then soared by 57.05% to -$17.2 million in 2021, then tumbled by 74.62% to -$30.1 million in 2022, then surged by 96.85% to -$945751.2 in 2023.
- The last three Profit After Tax figures came in at -$945751.2 (Q4 2023), -$30.1 million (Q4 2022), and -$17.2 million (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | -248.00 Mn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 438.21 Mn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 585.61 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 333.00 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -945,751.18 |
| Dec 31, 2022 | -30.06 Mn |
| Jun 30, 2021 | -17.22 Mn |
| Mar 31, 2021 | -10.66 Mn |
| Dec 31, 2020 | -40.08 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.50 Mn |
| Dec 31, 2019 | -33.45 Mn |